Weight Loss & Obesity News

September 16, 2024 — The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole new set of people will be learning the sometimes-intimidating skill.

September 13, 2024 — Obesity remains a significant health issue in the United States, even as weight loss drugs are getting more popular, according to new data from the CDC.

September 5, 2024 — Microplastics, found in food, beauty products, and in the air, may add to weight gain by mimicking hormones like cortisol, which can disrupt metabolism and increase obesity risk.

August 27, 2024 — The maker of the weight loss drug Zepbound is offering the drug at a reduced price for people willing to buy it directly from the company in vials, rather than auto-injector pens.

August 20, 2024 — The weight loss and diabetes drug tirzepatide, sold under the brand name Zepbound, was highly effective at reducing the risk of progressing from prediabetes to the more serious condition of type 2 diabetes, according to an early look at study results released Tuesday by drugmaker Eli Lilly.

August 7, 2024 — There are various options for managing weight after achieving weight loss goals with drugs. Maintaining lifestyle changes alongside medication adjustments is crucial for sustaining weight loss success.

August 6, 2024 — Compounded semaglutide is flooding the internet, and consumers are drowning in dosing errors. But problems also exist with the brand-name versions of the drugs.

August 5, 2024 — Researchers who bought the weight loss drug semaglutide online without a prescription were scammed or sent potentially toxic liquids that did not contain the labeled amount of the drug.

July 30, 2024 — Drugs for diabetes and weight loss like Ozempic and Wegovy show promise in helping people quit smoking, offering a surprising extra benefit for users.

July 23, 2024 — GLP-1 medicines like Ozempic were intended to treat diabetes, but their weight loss-inducing effects swiftly caught the nation’s attention. Over the past decade, the proportion of people using them for weight loss has doubled, while the proportion of people taking GLP-1s to treat diabetes is declining.

July 23, 2024 — Ozempic is already sometimes difficult to find. Now those who are using to drop a few pounds are making it harder for those who need it.

July 15, 2024 — New research suggests that taking Ozempic isn’t linked to an increased risk of 22 different brain or psychiatric disorders, ranging from dementia to drug addiction to depression and suicidality.

July 11, 2024 — More than 8 of 10 people who started taking drugs for weight loss stopped taking them within 2 years, according to a new analysis.

July 9, 2024 — In a head-to-head comparison of the weight loss drugs Mounjaro and Ozempic, Mounjaro came out on top for helping people lose more weight. It was also found to be more effective at leading to significant weight loss compared to Ozempic.

June 24, 2024 — Imagine losing twice as much weight just by getting supportive text messages and financial incentives. For men struggling with obesity, this innovative approach proved more effective than traditional weight management programs. Could this be the future of successful weight loss strategies?

June 13, 2024 — Doctors are offering surgical and nonsurgical treatments for “Ozempic face” for those who have facial aging after rapid weight loss from a GLP-1 medication.

June 4, 2024 — Semaglutide, found in weight loss drugs Ozempic and Wegovy, has been found to improve sensitivity to taste, perhaps explaining another way the medications help change food preferences and lead to weight loss.

June 3, 2024 — If you’re one of the many trying to start – or refill – a Wegovy or Zepbound prescription for weight loss, it’s tough out there. The new reality? Spending hours on the telephone with pharmacists and insurance company people.

May 29, 2024 — Weight loss drugs like Ozempic and Wegovy have taken the year by storm, with users hyping the extreme weight loss results, sometimes hundreds of pounds. These GLP-1 medications, which are used to treat diabetes and obesity, help suppress your appetite by keeping you fuller for longer. But what happens when these drugs don't bring you what you’d hoped? Here's what to know.

May 21, 2024 — Total weight loss was not significantly different between men and women in the surgery group. But in the non-surgery group, women lost 6.4%, compared to 4.8% among men, a significant difference.

May 14, 2024 — People with heart problems who took the weight loss drug Wegovy maintained an average weight loss of 10% of their body weight 4 years after starting the drug, according to newly released study results.

April 26, 2024 — Before there was Ozempic, there were these cost-friendly, safe, and highly effective weight loss drugs. FDA-approved obesity medication like orlistat (Xenical), phentermine/topiramate (Qsymia), and naltrexone/bupropion extended release (Contrave) have been on the market for decades.

April 24, 2024 — Weights, aerobics, and … Wegovy? Some in the fitness industry are moving to dispense the popular GLP-1 medications to club members, combining the new, easier method of losing weight with the old, more challenging one.

April 19, 2024 — A little visceral fat is helpful. It cushions your heart, lungs, and the organs in your gut. Too much, though, and it becomes a bad player. So what can you do to lessen your health risks?

April 12, 2024 — Endoscopic sleeve gastroplasty (ESG), a nonsurgical weight loss procedure, is more cost-effective over a 5-year period than using semaglutide, the active ingredient in Ozempic, Wegovy, and other weight loss drugs, a new study shows.

April 11, 2024 — A growing body of evidence shows that it's not just what and how much you eat that influence your health. How fast and when you eat also play a role.

March 29, 2024 — While applauding the role that these behavior-based weight management programs play in a comprehensive approach, an academic weight loss doctor thinks the order is backward.

March 15, 2024 — With summer months approaching – and pressures that come with showing more skin – more and more young adults are looking to GLP-1 medications, like Ozempic, to get prepped for “swimsuit season.” But experts say there are critical things to consider before reaching for such medications, particularly for those struggling with body image issues.

February 22, 2024 — It might not produce results as dramatic as regular injections, but you can get everything you need in a grocery store, for far less money -- and this approach has the potential to improve your health in numerous ways.

February 8, 2024 — People taking a popular type of drug for weight loss or to manage diabetes have a decreased likelihood of being newly diagnosed with depression or anxiety, according to an analysis of millions of people’s health records.

February 8, 2024 — People who take weight loss drugs should not neglect diet and exercise. Here's what to know.

February 5, 2024 — People with obesity who took the weight loss drug Zepbound experienced a reduction in blood pressure similar to or better than results usually seen with traditional hypertension drugs, a new analysis shows.

January 25, 2024 — For many of the 42 million Americans with obesity, weight loss medications such as Wegovy, Saxenda, and the brand-new Zepbound can be a godsend, helping them lose the excess pounds they’ve struggled with for decades or a lifetime.

January 24, 2024 — An analysis of health records for people who lost weight while being prescribed drugs like Wegovy, Saxenda, or Ozempic showed that many maintained most of their weight loss or continued to shed pounds within the year after their prescription ended.

January 23, 2024 — Loneliness has been known to be a serious health problem, and a new report makes the case that the suffering is worse for people who are obese.

January 11, 2024 — The FDA said Thursday that a review of a class of popular diabetes and obesity drugs found no connection between the medications and a rise in suicidal thoughts. The drugs include Ozempic, Wegovy, and Mounjaro.

January 5, 2024 — People taking semaglutide – the active ingredient in the weight loss drug Wegovy and the type 2 diabetes drug Ozempic – did not have an increase in suicidal thoughts, compared to people taking other drugs for those conditions, according to a study published in Nature Medicine.

January 4, 2024 — The FDA is formally looking into reports that some people who took popular diabetes and weight loss drugs had suicidal thoughts or two other health problems.

December 22, 2023 — The FDA says it has seized “thousands of units” of counterfeit Ozempic that are circulating while demand for the weight loss drug exceeds supply.

December 15, 2023 — A new way of looking at a misunderstood disease is revolutionizing treatments and transforming lives.

December 14, 2023 — New drugs being used for weight loss might bring results that are as temporary as they are dramatic, according to a study published this week in the Journal of the American Medical Association.

November 15, 2023 — German regulator BfArM is considering a halt on the export of Ozempic because high demand is creating a scarcity of the drug, Reuters reports.

November 8, 2023 — Suspected counterfeits of a popular weight loss drug are linked to the hospitalization of at least three people, federal data shows.

November 8, 2023 — The FDA on Wednesday approved an injection drug Zepbound for chronic weight management for adults with obesity or those who are overweight and have at least one weight-related condition, such as high blood pressure or high cholesterol.

October 20, 2023 — Research published this week shows that fructose may be the central factor driving obesity because it triggers cravings for fatty foods and carbohydrates, while blocking the body’s ability to use stored energy from fat.

October 18, 2023 — Many women on oral contraceptives are unaware that drugs like Mounjaro may result in the unexpected: pregnancy.

October 17, 2023 — The discovery from UCLA could open the door to new treatments for obesity and type 2 diabetes.

October 16, 2023 — People at high risk of getting type 2 diabetes lost on average more than 18% of their weight when taking the weight loss drug tirzepatide, according to clinical trial results published over the weekend.

October 6, 2023 — Counterfeit versions of the weight loss drug Ozempic are showing up in a variety of schemes, and sometimes the fraudulent offers are extremely realistic, a health care trade group warned its members this week.